Comparison of the Relative Oral Bioavailability of GKT137831 Formulated in Capsules or in Tablets

NCT03740217 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Phase 1

Interventions

DRUG: GKT137831

Sponsor

Calliditas Therapeutics AB

Collaborators

[object Object]
[object Object]